When Molly Gibson, PhD, joined Flagship Pioneering in 2017, she had been mulling over the question of what the main drivers of biology were for rethinking...
New research has shed light on why immune checkpoint blockade immunotherapy does not always work in some cancers with a high tumor mutational burden. The...
In this cell and gene therapy webinar, sponsored by Revvity, our distinguished speakers, Dr. Dominik Fischer and Dr. Michelle Fraser, will discuss recent...
'Gut Instinct' Cause For Numerous Sensory Symptoms In Long COVID, Doctors Offer Comprehensive Treatment Authored by Marina Zhang via The Epoch...
Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of September 11. Aside from presenting a synopsis of events, we provide market...
Short Squeeze Penny Stocks To Watch The post Penny Stocks To Buy? 3 Short Squeeze Stocks To Watch ASAP appeared first on Penny Stocks to Buy,...
MAPS just released huge news regarding their phase 3 trial readouts on PTSD, just published in Nature Medicine. This phase 3 trial was intended to evaluate...
WEST LAFAYETTE, Ind. – A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries....
Genetic testing can help take the guesswork out of finding the right treatment. For certain diseases. To an extent.
Despite decades of starts and stops, new treatments and key genetic discoveries are giving researchers great hope for slowing or eventually preventing...
The psychedelic sector received a material boost today, when late this morning, final MAPP2 MDMA-assisted therapy results were published in Nature Medicine....
SAN FRANCISCO, CA—In recent years, scientists have used gene modification technologies to reprogram immune cells into therapeutics that can attack cancers....
Researchers at the Harvard Wyss Institute have developed a technique that lets clinicians to characterize and monitor melanoma. The system involves using...
Irvine, CA – Sept. 14, 2023 – UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and neurodegeneration...
Genoa/Rome (Italy), 14th September 2023 – A tool that uses light to study biological molecules without interfering with their nanometric structure and...
Milan, September 13th, 2023. A new scientific study published in the prestigious international journal “Science Advances” has investigated one of...
CVS And Cigna Charge $6,000 For $55 Generics By Mish Shedlock of Mishtalk Health insurers dramatically mark up prices of generics and pharmacies...
Lukas Chavez, Ph.D., has received $3.2 million from the National Institutes of Health to study how unique DNA circles found in cancer cells drive deadly...
A new study has shed light on why immunotherapy does not always work in certain types of cancer. Led by researchers at EMBL’s European Bioinformatics...
DNA mismatch repair deficiency (MMRd) is a genetic condition often associated with colon cancer. It can happen in otherwise normal cells before cancer...
The Norrsken Foundation, a non-profit impact ecosystem “connecting founders with the capital, knowledge and network they need to make saving the world...
New company AlveoGene, backed by experts at the UK Respiratory Gene Therapy Consortium (GTC), has made its debut with a lead program for rare respiratory...
“With these new drugs now available in clinical practice, we expect HER2+/HER2-low BC patients with BMs to live longer and to live better.” Credit:...
For the first time in one year, three faculty at the University of Oklahoma have received Maximizing Investigators’ Research Awards from the National...
A deal with Ferring Pharmaceuticals last month represented Royalty Pharma’s first foray into gene therapy royalties, and it’s already raising questions...
Futures Drift Lower Ahead Of CPI Report S&P 500, Nasdaq 100 futures drifted lower overnight, and were last down modestly ahead of the...
With the decriminalization of psychedelic compounds looking like a real possibility this upcoming election cycle, opposing forces are speaking out. The...
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) has recently seen a substantial intraday gain of over 15% in its share price. Despite the absence...
Researchers at Stanford University have developed a new type of cancer therapy. The technology targets mucins, sugar-coated proteins that help cancer cells...
With an early-stage CAR-T under clinical hold, 2seventy bio is slashing its headcount by 40% and capping spending on some pipeline programs to focus on...